Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent
1993-11-08
1998-01-20
Caputa, Anthony C.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
4242661, 4242671, 530324, 530350, A61K 39002, A61K 39012, C07K 14455
Patent
active
057098620
ABSTRACT:
A cloned gene or fragment thereof encodes antigenic proteins that bind with a monoclonal or polyvalent antibody that is directed against an antigenic protein of avian coccidia.
REFERENCES:
patent: 4336336 (1982-06-01), Silhavy et al.
patent: 4466917 (1984-08-01), Nussenzweig et al.
patent: 4569794 (1986-02-01), Smith et al.
patent: 4639372 (1987-01-01), Murray et al.
patent: 4650576 (1987-03-01), Leary et al.
patent: 4710377 (1987-12-01), Schenkel et al.
patent: 4808404 (1989-02-01), Bhogal
patent: 4874705 (1989-10-01), Andrews et al.
patent: 5028694 (1991-07-01), Mewman, Jr. et al.
Bennink et al., "Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells," Nature 311:578-579 (Oct. 11, 1984).
Clarke et al., "Isolation of .lambda.amp3 genomic recombinants coding for antigens of Eimeria tenella," Chem. Abst. 106:Abstr.#132966m (1987).
Danforth, H., "Development of hybridoma-produced antibodies directed against Eimeria tenella and E. mitis," J. Parasitol. 68:392-397 (1982).
Danforth et al., "Genetically Engineered Antigen Confers Partial Protection Against Avian Coccidial Parasites," Poultry Sci. 68:1643-1652 (1989).
Kemp, "Expression of Plasmodium falciparum blood-stage antigens in Escherichia coli: Detection with antibodies from immune humans," PNAS 80:3787-3791 (Jun. 1983).
Lerner, R., "Synthetic Vaccines," Scientific American 248:66-74 (Feb. 1983).
Mackett et al., "Vaccinia virus: A selectable eukaryotic cloning and expression vector," PNAS 79:7415-7419 (Dec. 1982).
Mackett et al., "General Method for Production and Selection of Infectious Vaccinia Virus Recombinants Expressing Foreign Genes," J. Virol. 49:857-864 (Mar. 1984).
Miller et al., "Characterization and Vaccine Potential of a Novel Recombinant Coccidial Antigen," Infect. Immun. 57:2014-2020 (Jul. 1989).
Panicali & Paoletti, "Construction of poxviruses as cloning vectors: Insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus," PNAS 79:4927-4931 (Aug. 1982).
Smith & Clegg, "Vaccination Against Schistosoma mansoni with Purified Surface Antigens," Science 227:53-538 (Feb. 1, 1985).
Young & Davis, "Efficient isolation of genes by using antibody probes," PNAS 80:1194-1195 (Mar. 1983).
Anderson David M.
Augustine Patricia C.
Danforth Harry D.
McCandliss Russell J.
Ruff Michael D.
British Technology Group USA Inc.
Caputa Anthony C.
The United States of America as represented by the Department of
LandOfFree
Isolated protein from Eimeria useful as a cross species vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolated protein from Eimeria useful as a cross species vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolated protein from Eimeria useful as a cross species vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-723407